OUR PRODUCTS

MOBILE APPS

GENERAL INFO

URGN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

UroGen Pharma (URGN) Earnings Date & Reports

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

URGN is expected to report earnings to fall 9.37% to -83 cents per share on August 07

UroGen Pharma URGN Stock Earnings Reports

Q2'25

Est.

$-0.83

Q1'25

Missed

by $0.13

Q4'24

Missed

by $0.03

Q3'24

Beat

by $0.27

Q2'24

Missed

by $0.08

The last earnings report on May 12 showed earnings per share of -92 cents, missing the estimate of -79 cents. With 553.70K shares outstanding, the current market capitalization sits at 924.49M.

View a ticker or compare two or three

Compare

URGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For URGN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. URGN showed earnings on May 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapies for urological pathologies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

400 Alexander Park Drive

Phone

+1 646 768-9780

Employees

201

Web

https://www.urogen.com